State of the Science for Kidney Disorders in Phelan-McDermid Syndrome: UPK3A, FBLN1, WNT7B, and CELSR1 as Candidate Genes

Genes (Basel). 2022 Jun 10;13(6):1042. doi: 10.3390/genes13061042.

Abstract

Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder caused by chromosomal rearrangements affecting the 22q13.3 region or by SHANK3 pathogenic variants. The scientific literature suggests that up to 40% of individuals with PMS have kidney disorders, yet little research has been conducted on the renal system to assess candidate genes attributed to these disorders. Therefore, we first conducted a systematic review of the literature to identify kidney disorders in PMS and then pooled the data to create a cohort of individuals to identify candidate genes for renal disorders in PMS. We found 7 types of renal disorders reported: renal cysts, renal hypoplasia or agenesis, hydronephrosis, vesicoureteral reflux, kidney dysplasia, horseshoe kidneys, and pyelectasis. Association analysis from the pooled data from 152 individuals with PMS across 22 articles identified three genomic regions spanning chromosomal bands 22q13.31, 22q13.32, and 22q13.33, significantly associated with kidney disorders. We propose UPK3A, FBLN1, WNT7B, and CELSR1, located from 4.5 Mb to 5.5 Mb from the telomere, as candidate genes. Our findings support the hypothesis that genes included in this region may play a role in the pathogenesis of kidney disorders in PMS.

Keywords: 22q13.3 deletion syndrome; Phelan-McDermid syndrome; kidney disorders; urogenital anomalies.

Publication types

  • Review

MeSH terms

  • Chromosome Deletion
  • Chromosome Disorders* / genetics
  • Chromosomes, Human, Pair 22 / genetics
  • Humans
  • Kidney / pathology
  • Phenotype
  • Wnt Proteins / genetics

Substances

  • WNT7B protein, human
  • Wnt Proteins

Supplementary concepts

  • Telomeric 22q13 Monosomy Syndrome

Grants and funding

Publication support was provided by the Clemson University Center for Research on Health Disparities and the Clemson University Open Access Publishing Fund.